TD Cowen Maintains Buy on Astrana Health, Raises Price Target to $50
Benzinga Newsdesk 4 months ago
Analyst RatingsNewsPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
TD Cowen analyst Ryan Langston maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $45 to $50.
TD Cowen analyst Ryan Langston maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $45 to $50.
